Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Promising efficacy of UTI vaccines as an alternative to antibiotics

Nature Reviews Urology volume 21, pages 701–702 (2024)Cite this article

Subjects

Antibiotics are the mainstay prophylaxis and treatment for recurrent urinary tract infections (UTIs). However, antibiotic resistance is rising globally, leading to infections that are harder to treat. In view of this resistance, alternative, non-antibiotic treatments for recurrent UTIs are now being developed; among them, UTI vaccines have shown promising results.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Unemo, M. et al. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. Sex. Health 16, 412–425 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ventola, C. L. The antibiotic resistance crisis: part 1: causes and threats. P T 40, 277–283 (2015).

    PubMed  PubMed Central  Google Scholar 

  3. Ikäheimo, R. et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin. Infect. Dis. 22, 91–99 (1996).

    Article  PubMed  Google Scholar 

  4. Sihra, N., Goodman, A., Zakri, R., Sahai, A. & Malde, S. Nonantibiotic prevention and management of recurrent urinary tract infection. Nat. Rev. Urol. 15, 750–776 (2018).

    Article  PubMed  Google Scholar 

  5. Benito-Villalvilla, C. et al. MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88. Mucosal Immunol. 10, 924–935 (2017).

    Article  CAS  PubMed  Google Scholar 

  6. Carrión-López, P. et al. Cost-effectiveness of a sublingual bacterial vaccine for the prophylaxis of recurrent urinary tract infections. Urol. Int. 106, 730–736 (2022).

    Article  PubMed  Google Scholar 

  7. Kanabar, S., Foley, S. & Yang, B. Assessing the long-term efficacy and safety of MV140 sublingual bacterial vaccine in the initial cohort: a 9-year study in the UK for treating recurrent urinary tract infections in men and women [abstract]. Eur. Urol. 85, S1037 (2024).

    Article  Google Scholar 

  8. Mak, Q., Greig, J., Dasgupta, P., Malde, S. & Raison, N. Bacterial vaccines for the management of recurrent urinary tract infections: a systematic review and meta-analysis. Eur. Urol. Focus https://doi.org/10.1016/j.euf.2024.04.002 (2024).

    Article  PubMed  Google Scholar 

  9. Perrotta, C., Aznar, M., Mejia, R., Albert, X. & Ng, C. W. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst. Rev. 2, CD005131 (2008).

    Google Scholar 

  10. Lorenzo-Gómez, M. F. et al. Comparison of sublingual therapeutic vaccine with antibiotics for the prophylaxis of recurrent urinary tract infections. Front. Cell. Infect. Microbiol. 5, 50 (2015).

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. GKT School of Medical Education, King’s College London, London, UK

    Quentin Mak

  2. Birmingham Medical School, University of Birmingham, Birmingham, UK

    Julian Greig

  3. Department of Urology, Guy’s & St Thomas’ NHS Trust, London, UK

    Prokar Dasgupta & Sachin Malde

  4. School of Immunology and Microbial Sciences, King’s College London, Guy’s Hospital, London, UK

    Prokar Dasgupta

  5. Department of Urology, King’s College Hospital NHS Foundation Trust, London, UK

    Nicholas Raison

  6. School of Biomedical Engineering and Imaging Sciences, King’s College London, London, UK

    Nicholas Raison

Authors
  1. Quentin Mak
    View author publications

    Search author on:PubMed Google Scholar

  2. Julian Greig
    View author publications

    Search author on:PubMed Google Scholar

  3. Prokar Dasgupta
    View author publications

    Search author on:PubMed Google Scholar

  4. Sachin Malde
    View author publications

    Search author on:PubMed Google Scholar

  5. Nicholas Raison
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Quentin Mak.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mak, Q., Greig, J., Dasgupta, P. et al. Promising efficacy of UTI vaccines as an alternative to antibiotics. Nat Rev Urol 21, 701–702 (2024). https://doi.org/10.1038/s41585-024-00905-8

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41585-024-00905-8

Search

Advanced search

Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology